Cargando…

Meeting report: the 2020 FSHD International Research Congress

Detalles Bibliográficos
Autores principales:	Kyba, Michael, Bloch, Robert J., Dumonceaux, Julie, Harper, Scott Q., van der Maarel, Silvère M., Sverdrup, Francis M., Wagner, Kathryn R., van Engelen, Baziel, Chen, Yi-Wen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Meeting Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7721607/ https://www.ncbi.nlm.nih.gov/pubmed/33292505 http://dx.doi.org/10.1186/s13395-020-00253-2

Ejemplares similares

Meeting report: the 2021 FSHD International Research Congress
por: Jagannathan, Sujatha, et al.
Publicado: (2022)

Intrinsic Epigenetic Regulation of the D4Z4 Macrosatellite Repeat in a Transgenic Mouse Model for FSHD
por: Krom, Yvonne D., et al.
Publicado: (2013)

Facioscapulohumeral dystrophy in children: design of a prospective, observational study on natural history, predictors and clinical impact (iFocus FSHD)
por: Goselink, Rianne J. M., et al.
Publicado: (2016)

Therapeutic Strategies Targeting DUX4 in FSHD
por: Le Gall, Laura, et al.
Publicado: (2020)

Consequences of epigenetic derepression in facioscapulohumeral muscular dystrophy
por: Greco, Anna, et al.
Publicado: (2020)

BET bromodomain inhibitors and agonists of the beta-2 adrenergic receptor identified in screens for compounds that inhibit DUX4 expression in FSHD muscle cells
por: Campbell, Amy E., et al.
Publicado: (2017)

The FSHD muscle–blood biomarker: a circulating transcriptomic biomarker for clinical severity in facioscapulohumeral muscular dystrophy
por: Banerji, Christopher R S, et al.
Publicado: (2023)

DUX4 Binding to Retroelements Creates Promoters That Are Active in FSHD Muscle and Testis
por: Young, Janet M., et al.
Publicado: (2013)

DUX4 Expression in FSHD Muscles: Focus on Its mRNA Regulation
por: Sidlauskaite, Eva, et al.
Publicado: (2020)

Gene Editing Targeting the DUX4 Polyadenylation Signal: A Therapy for FSHD?
por: Joubert, Romains, et al.
Publicado: (2020)

The facioscapulohumeral muscular dystrophy Rasch‐built overall disability scale (FSHD‐RODS)
por: Mul, Karlien, et al.
Publicado: (2021)

Effect of aerobic exercise training and cognitive behavioural therapy on reduction of chronic fatigue in patients with facioscapulohumeral dystrophy: protocol of the FACTS-2-FSHD trial
por: Voet, Nicoline BM, et al.
Publicado: (2010)

Correlation Between Quantitative MRI and Muscle Histopathology in Muscle Biopsies from Healthy Controls and Patients with IBM, FSHD and OPMD
por: Lassche, Saskia, et al.
Publicado: (2020)

Molecular Diagnosis of Facioscapulohumeral Muscular Dystrophy in Patients Clinically Suspected of FSHD Using Optical Genome Mapping
por: Guruju, Naga M., et al.
Publicado: (2023)

SMCHD1 and LRIF1 converge at the FSHD-associated D4Z4 repeat and LRIF1 promoter yet display different modes of action
por: Šikrová, Darina, et al.
Publicado: (2023)

Asymmetric Bidirectional Transcription from the FSHD-Causing D4Z4 Array Modulates DUX4 Production
por: Block, Gregory J., et al.
Publicado: (2012)

FSHD / OPMD / MYOTONIC DYSTROPHY: P.229 Open-Label study of losmapimod evaluating safety, tolerability, and changes in biomarker and clinical outcome assessments in subjects with FSHD1
por: Mellion, M., et al.
Publicado: (2020)

Biphasic Myopathic Phenotype of Mouse DUX, an ORF within Conserved FSHD-Related Repeats
por: Bosnakovski, Darko, et al.
Publicado: (2009)

miRNA Expression in Control and FSHD Fetal Human Muscle Biopsies
por: Portilho, Débora Morueco, et al.
Publicado: (2015)

Clinical trial readiness to solve barriers to drug development in FSHD (ReSolve): protocol of a large, international, multi-center prospective study
por: LoRusso, Samantha, et al.
Publicado: (2019)

Meeting report on the first Iranian congress of electrodiagnosis in peripheral nerve lesions
por: Rayegani, Seyed M, et al.
Publicado: (2007)

Transplantation of PSC-derived myogenic progenitors counteracts disease phenotypes in FSHD mice
por: Azzag, Karim, et al.
Publicado: (2022)

A proteomics study identifying interactors of the FSHD2 gene product SMCHD1 reveals RUVBL1-dependent DUX4 repression
por: Goossens, Remko, et al.
Publicado: (2021)

Digenic inheritance of an SMCHD1 mutation and an FSHD-permissive D4Z4 allele causes facioscapulohumeral muscular dystrophy type 2
por: Lemmers, Richard J.L.F., et al.
Publicado: (2012)

Designed U7 snRNAs inhibit DUX4 expression and improve FSHD-associated outcomes in DUX4 overexpressing cells and FSHD patient myotubes
por: Rashnonejad, Afrooz, et al.
Publicado: (2020)

Proceedings of Réanimation 2020, the French Intensive Care Society International Congress
Publicado: (2020)

DNA aptamers against the DUX4 protein reveal novel therapeutic implications for FSHD
por: Klingler, Christian, et al.
Publicado: (2020)

Meeting Abstracts from the 77th Congress of the Italian Society of Pediatrics
Publicado: (2023)

First Virtual International Congress on Cellular and Organismal Stress Responses, November 5–6, 2020
por: van Oosten-Hawle, Patricija, et al.
Publicado: (2021)

Highlights from Science Policy Interface sessions at the One Health Congress 2020
por: Vanlangendonck, Chris, et al.
Publicado: (2021)

Ophthalmological findings in facioscapulohumeral dystrophy
por: Goselink, Rianne J M, et al.
Publicado: (2019)

IFSC 2020 Meeting Report
por: Lappin, Terry
Publicado: (2021)

Muscle pathology from stochastic low level DUX4 expression in an FSHD mouse model
por: Bosnakovski, Darko, et al.
Publicado: (2017)

Profiling Serum Antibodies Against Muscle Antigens in Facioscapulohumeral Muscular Dystrophy Finds No Disease-Specific Autoantibodies
por: Greco, Anna, et al.
Publicado: (2021)

Nuclear entrapment and extracellular depletion of PCOLCE is associated with muscle degeneration in oculopharyngeal muscular dystrophy
por: Raz, Vered, et al.
Publicado: (2013)

Immunotherapy Bridge 2020 and Melanoma Bridge 2020: meeting abstracts
Publicado: (2021)

Proceedings of the 26th European Paediatric Rheumatology Congress (PReS 2020) - Late Breaking Abstracts: Virtual. 23 - 25 September 2020
Publicado: (2020)

XVII Meeting of the Academy AIPMB and I National Congress SPPMB : December 2-3, 2022
Publicado: (2023)

Abstracts from the International Congress on Neuromuscular Diseases, September 11-14, 2020: A Virtual Event
por: Vilchez Padilla, Juan Jesús
Publicado: (2021)

TT2020 meeting report on the 16th Transgenic Technology Meeting
por: Hinttala, Reetta, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_0puc7gfrn4u0ae7q15a4nudh6u